about
Fluid Resuscitation in SepsisCorticosteroids for treating sepsisNocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disordersMechanical ventilation for amyotrophic lateral sclerosis/motor neuron diseasePlasma exchange for Guillain-Barré syndromeInvasive versus non-invasive ventilation for acute respiratory failure in neuromuscular disease and chest wall disordersMechanical ventilation for amyotrophic lateral sclerosis/motor neuron diseaseNocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disordersPsychostimulants for hypersomnia (excessive daytime sleepiness) in myotonic dystrophyCorticosteroids for treating severe sepsis and septic shockMechanical ventilation for amyotrophic lateral sclerosis/motor neuron diseaseCorticosteroids for severe sepsis and septic shock: a systematic review and meta-analysisCortisol replacement for severe sepsis and septic shock: what should I do?Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoidsScience review: The brain in sepsis--culprit and victim.Clinical review: corticotherapy in sepsisThe Role of ACTH and Corticosteroids for Sepsis and Septic Shock: An UpdateThe Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)Year in review 2010: Critical Care--Multiple organ dysfunction and sepsisReducing mortality in sepsis: new directionsThe effects of etomidate on adrenal responsiveness and mortality in patients with septic shockHydrocortisone therapy for patients with septic shockRecommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care MedicineSurviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012Clinical research ethics for critically ill patients: a pandemic proposal.Designing and conducting a randomized trial for pandemic critical illness: the 2009 H1N1 influenza pandemic.Dynamic data during hypotensive episode improves mortality predictions among patients with sepsis and hypotension.The encephalopathy in sepsis.Improving clinical trials in the critically ill: unique challenge--sepsis.Human plasma quantification of fludrocortisone using liquid chromatography coupled with atmospheric pressure chemical ionization mass spectrometry after low-dosage administration.Brainstem response patterns in deeply-sedated critically-ill patients predict 28-day mortality.Pattern of brain injury in the acute setting of human septic shockEarly impairment of intracranial conduction time predicts mortality in deeply sedated critically ill patients: a prospective observational pilot studyDetection of Campylobacter jejuni by culture and real-time PCR in a French cohort of patients with Guillain-Barre syndrome.Thirty years of critical care medicine.Changes in CRH and ACTH synthesis during experimental and human septic shockEffect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.Managing toxic shock syndrome with antibiotics.Clinical practice guideline on diagnosis and treatment of hyponatraemia.Cognitive decline after sepsis.
P50
Q22305304-F450D2E1-E1DE-482B-90B1-71130D91CD80Q24187207-8009D3CB-FC37-4889-BABD-585CB5E02F15Q24187323-2FFBD65D-60CC-4509-A471-439DFA766188Q24199018-FFCA6547-1656-40E4-B179-8BFB22018BD0Q24202179-A92D1A55-CD39-4EE9-95F7-D016BA441104Q24240146-210C5A9C-F758-4858-842D-86C2490753BCQ24240593-978F07B8-F9E2-48C5-9E14-9A7EF2830989Q24243245-C5511931-EDB8-45CA-AAA0-D869BB027410Q24245250-2C6B31C3-6141-41E0-8968-86D1D2C07917Q24247427-BC7F010A-EAC4-4B2A-ADF6-788717354119Q24247818-34BDC047-25D5-44FD-9434-956F7C344B57Q24562848-3301D036-0867-4FAA-AD75-645D62B76EB2Q24798383-61C0EC72-C104-4B30-BA5E-B7A09B872A94Q24798383-EC1EF407-2EFC-492C-874C-D7078E4F2380Q24800806-F1174049-F921-4701-93F3-1977F2482AEFQ24802170-0E28C34A-E264-4BAE-B534-A26D0BCEC911Q24802170-F5C66067-F042-4B88-A450-05E18099190EQ24805270-09D40B68-41A8-4DE4-8CBB-A788F25B8BF2Q26744591-17B1F63F-F8DA-4546-9AFE-90B98A9834F4Q26768286-0296331B-02F0-4C50-9C84-9001AFF3752AQ26823098-E74F0B36-1DC9-4186-A122-81A527FE5BFFQ28195791-EBB3A021-A153-4461-8184-A63786557B45Q28253821-8825B5C4-45F3-42B8-927F-28853A83C885Q28264225-5F84AF20-1109-437C-9F32-1C247025D127Q28280888-D12A0191-E1AF-4A0B-A842-B8110F30C330Q28284276-A48AC473-F4A6-4EF8-9C2D-D0E2FD94A5E2Q30383773-A70101D1-AA65-47F1-BC43-59C4FFFD3256Q30410015-201EC389-827B-4BE8-99A2-EBCBD4FDDCC1Q30587096-1B4220E6-E74D-4909-87A5-2CE33947BF40Q31145115-1DD9E4C5-E10A-4C65-9606-84C50A4C579EQ33395230-6D783BBC-09C5-4CC0-8D1B-315D322BF0FAQ33456610-D6009499-A3EA-4B2D-AD69-216B9A8FA58BQ33602499-11463D16-7905-4ADA-9D18-B161A6F08ED7Q33753392-FABA8098-D6A4-4CF6-9B5F-BBC7DDD02EA1Q33789959-9A13128A-5645-46CE-8C84-F0CB284CACE0Q33909538-F07996F6-5CCC-4D13-BE18-16125FD5302AQ34026781-2AD0D196-1D99-455E-BFD4-41C6815B8052Q34071510-17FA31AB-86FD-4FEC-9735-43878A3B3DB4Q34145159-0BCEB3D6-FAFC-45B6-8029-69AED9E48313Q34334680-250F0535-7B2D-4405-8832-D38BB89010C2
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Djillali Annane
@ast
Djillali Annane
@en
Djillali Annane
@es
Djillali Annane
@nl
Djillali Annane
@sl
type
label
Djillali Annane
@ast
Djillali Annane
@en
Djillali Annane
@es
Djillali Annane
@nl
Djillali Annane
@sl
prefLabel
Djillali Annane
@ast
Djillali Annane
@en
Djillali Annane
@es
Djillali Annane
@nl
Djillali Annane
@sl
P106
P21
P31
P4434
ANNANE,200593